Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide.
Jakob Schöllhammer KnudsenReimar Wernich ThomsenAnton PottegårdFilip Krag KnopHenrik Toft SørensenPublished in: Diabetes care (2018)